CPT® Code 81361

HBB (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); common variant(s) (eg, HbS, HbC, HbE)

The CPT® Code 81361 pertains to the analysis of the HBB gene, which encodes the beta-globin subunit of hemoglobin, a critical protein found in red blood cells (RBCs). This gene analysis is particularly relevant for identifying common variants associated with various hemoglobin disorders, including sickle cell anemia, beta thalassemia, and other hemoglobinopathies. The HBB gene is located on the short arm of chromosome 11 and plays a vital role in the formation of hemoglobin, which is composed of two beta-globin and two alpha-globin subunits. These subunits are essential for binding oxygen, which is then transported throughout the body by RBCs. Mutations in the HBB gene can lead to significant health issues. For instance, in sickle cell anemia, a specific mutation results in the substitution of the amino acid glutamic acid with valine at position 6 of the beta-globin chain, leading to the production of hemoglobin S (HbS). This abnormal hemoglobin causes RBCs to assume a sickle shape, which can obstruct blood flow and lead to various complications. Similarly, beta thalassemia is characterized by mutations that either reduce or completely halt the production of beta-globin, resulting in anemia and related symptoms due to insufficient oxygen delivery to tissues. The HBB gene analysis can be performed using techniques such as polymerase chain reaction (PCR) and sequencing, which allow for the detection of these mutations. The test is crucial for diagnosing hemoglobin disorders, determining carrier status in individuals with a family history of such conditions, and guiding clinical management. The code 81361 specifically reports testing for common variants like HbS, HbC, and HbE, which are prevalent in certain populations and can lead to similar clinical manifestations due to their impact on hemoglobin function.